2 months Biomarin: Challanges Mount, But Sale Rumours Make For A Risky “Buy” Call Seeking Alpha Biomarin: Challanges Mount, But Sale Rumours Make For A Risky “Buy” Call. Biomarin Pharma (BMRN) X